Laura Chico
Stock Analyst at Wedbush
(4.79)
# 534
Out of 4,517 analysts
617
Total ratings
53.7%
Success rate
14.6%
Average return
Main Sectors:
Stocks Rated by Laura Chico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Maintained: Hold | $196 → $201 | $208.92 | -3.79% | 68 | Jul 15, 2026 | |
| BCRX BioCryst Pharmaceuticals | Maintained: Buy | $21 | $9.11 | +130.64% | 16 | Jul 13, 2026 | |
| NBIX Neurocrine Biosciences | Maintained: Buy | $166 → $185 | $171.55 | +7.84% | 24 | Jul 13, 2026 | |
| TVTX Travere Therapeutics | Maintained: Buy | $61 | $55.28 | +10.35% | 34 | Jul 13, 2026 | |
| RARE Ultragenyx Pharmaceutical | Rated: Hold | $26 → $30 | $30.22 | -0.73% | 53 | Jul 13, 2026 | |
| ARDX Ardelyx | Maintained: Buy | $11 → $19 | $5.13 | +270.73% | 19 | Jul 13, 2026 | |
| VRDN Viridian Therapeutics | Maintained: Buy | $43 | $18.03 | +138.49% | 73 | Jul 13, 2026 | |
| DNLI Denali Therapeutics | Maintained: Buy | $23 → $26 | $22.73 | +14.39% | 27 | Jul 13, 2026 | |
| VERA Vera Therapeutics | Maintained: Hold | $47 → $43 | $39.12 | +9.92% | 11 | Jul 13, 2026 | |
| JBIO Jade Biosciences | Maintained: Buy | n/a | $20.48 | - | 11 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $12.58 | - | 6 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $3.67 | +226.98% | 7 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 | $38.19 | +36.16% | 25 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 | $95.35 | +10.12% | 15 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $166 → $162 | $308.20 | -47.44% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.1705 | +486.51% | 6 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $16 | $9.05 | +76.80% | 8 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $45.29 | +17.02% | 3 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $24 | $27.33 | -12.18% | 10 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $2.45 | +185.71% | 12 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $33.66 | +24.78% | 8 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $4 | $2.25 | +77.78% | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $48 | $27.17 | +76.70% | 6 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $14.10 | +183.69% | 3 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 | $66.98 | -5.94% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $29.11 | +30.54% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $7 | $3.04 | n/a | 10 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $15.96 | n/a | 4 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $12.61 | n/a | 8 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $5 | $5.97 | n/a | 5 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $4.91 | n/a | 4 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $45 | $0.9762 | n/a | 5 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $60.00 | n/a | 15 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $486.03 | n/a | 16 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.03 | n/a | 10 | Sep 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.80 | n/a | 4 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $678.94 | n/a | 16 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $8.80 | n/a | 1 | Jan 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.6136 | n/a | 1 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $45.82 | n/a | 1 | Dec 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $3.08 | n/a | 1 | Jun 30, 2017 |
Biogen
Jul 15, 2026
Maintained: Hold
Price Target: $196 → $201
Current: $208.92
Upside: -3.79%
BioCryst Pharmaceuticals
Jul 13, 2026
Maintained: Buy
Price Target: $21
Current: $9.11
Upside: +130.64%
Neurocrine Biosciences
Jul 13, 2026
Maintained: Buy
Price Target: $166 → $185
Current: $171.55
Upside: +7.84%
Travere Therapeutics
Jul 13, 2026
Maintained: Buy
Price Target: $61
Current: $55.28
Upside: +10.35%
Ultragenyx Pharmaceutical
Jul 13, 2026
Rated: Hold
Price Target: $26 → $30
Current: $30.22
Upside: -0.73%
Ardelyx
Jul 13, 2026
Maintained: Buy
Price Target: $11 → $19
Current: $5.13
Upside: +270.73%
Viridian Therapeutics
Jul 13, 2026
Maintained: Buy
Price Target: $43
Current: $18.03
Upside: +138.49%
Denali Therapeutics
Jul 13, 2026
Maintained: Buy
Price Target: $23 → $26
Current: $22.73
Upside: +14.39%
Vera Therapeutics
Jul 13, 2026
Maintained: Hold
Price Target: $47 → $43
Current: $39.12
Upside: +9.92%
Jade Biosciences
Jul 10, 2026
Maintained: Buy
Price Target: n/a
Current: $20.48
Upside: -
Jul 10, 2026
Maintained: Buy
Price Target: n/a
Current: $12.58
Upside: -
Jun 30, 2026
Maintained: Buy
Price Target: $12
Current: $3.67
Upside: +226.98%
Jun 17, 2026
Maintained: Buy
Price Target: $52
Current: $38.19
Upside: +36.16%
Jun 15, 2026
Maintained: Buy
Price Target: $105
Current: $95.35
Upside: +10.12%
Jun 2, 2026
Maintained: Sell
Price Target: $166 → $162
Current: $308.20
Upside: -47.44%
May 19, 2026
Maintained: Hold
Price Target: $1
Current: $0.1705
Upside: +486.51%
May 18, 2026
Maintained: Buy
Price Target: $17 → $16
Current: $9.05
Upside: +76.80%
May 18, 2026
Maintained: Buy
Price Target: $53
Current: $45.29
Upside: +17.02%
May 14, 2026
Maintained: Hold
Price Target: $21 → $24
Current: $27.33
Upside: -12.18%
May 13, 2026
Maintained: Buy
Price Target: $7
Current: $2.45
Upside: +185.71%
May 13, 2026
Maintained: Buy
Price Target: $42
Current: $33.66
Upside: +24.78%
May 13, 2026
Maintained: Buy
Price Target: $5 → $4
Current: $2.25
Upside: +77.78%
May 13, 2026
Maintained: Buy
Price Target: $58 → $48
Current: $27.17
Upside: +76.70%
May 12, 2026
Reiterated: Buy
Price Target: $40
Current: $14.10
Upside: +183.69%
May 8, 2026
Maintained: Buy
Price Target: $63
Current: $66.98
Upside: -5.94%
May 8, 2026
Maintained: Buy
Price Target: $38
Current: $29.11
Upside: +30.54%
Aug 7, 2024
Maintained: Hold
Price Target: $8 → $7
Current: $3.04
Upside: n/a
Apr 11, 2024
Maintained: Buy
Price Target: $13 → $11
Current: $15.96
Upside: n/a
Mar 20, 2024
Maintained: Hold
Price Target: $5
Current: $12.61
Upside: n/a
Aug 12, 2022
Maintained: Buy
Price Target: $22 → $5
Current: $5.97
Upside: n/a
Feb 11, 2022
Maintained: Buy
Price Target: $23
Current: $4.91
Upside: n/a
Aug 11, 2020
Maintained: Hold
Price Target: $3 → $45
Current: $0.9762
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $60.00
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $486.03
Upside: n/a
Sep 12, 2018
Downgraded: Hold
Price Target: n/a
Current: $15.03
Upside: n/a
Aug 13, 2018
Maintained: Hold
Price Target: n/a
Current: $1.80
Upside: n/a
Aug 8, 2018
Maintained: Hold
Price Target: n/a
Current: $678.94
Upside: n/a
Jan 18, 2018
Initiated Coverage: Buy
Price Target: $24
Current: $8.80
Upside: n/a
Jan 4, 2018
Reiterated: Hold
Price Target: n/a
Current: $0.6136
Upside: n/a
Dec 7, 2017
Reiterated: Buy
Price Target: n/a
Current: $45.82
Upside: n/a
Jun 30, 2017
Maintained: Buy
Price Target: $30
Current: $3.08
Upside: n/a